Three new RA drugs reach Europe
This article was originally published in Scrip
Executive Summary
The European Commission approved two anti-TNF drugs for the treatment of rheumatoid arthritis, while the first-IL-6 receptor antagonist, Roche's RoActemra, was launched in the UK for RA in the same week.